Halozyme Therapeutics
HALO
#2478
Rank
โ‚น490.61 B
Marketcap
โ‚น3,856
Share price
-15.40%
Change (1 day)
17.39%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น17.9 M-29.77%
2023โ‚น25.5 M-15.59%
2022โ‚น30.2 M38.39%
2021โ‚น21.82 M-6.23%
2020โ‚น23.27 M-44.23%
2019โ‚น41.74 M591.9%
2018โ‚น6.03 M-64.48%
2017โ‚น16.98 M-5.65%
2016โ‚น17.99 M-13.05%
2015โ‚น20.7 M-7.81%
2014โ‚น22.45 M140.61%
2013โ‚น9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น0.65 Mโ‚น13.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น41.73 Mโ‚น0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.62 Mโ‚น53.13 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.21 Mโ‚น0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.64 Mโ‚น71.88 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น70.18 Mโ‚น0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA